ContractExecutive Stock Option Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.17 3 ex10_17.htm EXHIBIT 10.17 Exhibit 10.17 EXECUTIVE STOCK OPTION AGREEMENT UNDER THE EDGE THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN THIS STOCK OPTION AGREEMENT (this “Agreement”) between Edge Therapeutics, Inc. (the “Corporation” or the “Company”) and the individual specified on the Notice of Grant (the “Optionee”) is made as of the date of grant specified on the Notice of Grant to which this Agreement is attached (the “Grant Notice”). The date of grant specified on the Grant Notice is referred to herein as the “Grant Date.” RECITALS WHEREAS, the Corporation maintains the Edge Therapeutics, Inc. 2014 Equity Incentive Plan (the “Plan”) for the benefit of its employees, directors and consultants; and WHEREAS, the Plan permits the Corporation to award options with respect to shares of the Corporation’s common stock, $0.00033 par value per share (“Shares”), subject to the terms of the Plan. NOW, THEREFORE, in consideration of these premises and the agreements set forth herein,
EXECUTIVE STOCK OPTION AGREEMENTExecutive Stock Option Agreement • June 4th, 2019 • PDS Biotechnology Corp • Pharmaceutical preparations • Delaware
Contract Type FiledJune 4th, 2019 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT (this “Agreement”) between PDS Biotechnology Corporation (the “Corporation” or the “Company”) and the individual specified on the Notice of Grant (the “Optionee”) is made as of the date of grant specified on the Notice of Grant to which this Agreement is attached (the “Grant Notice”). The date of grant specified on the Grant Notice is referred to herein as the “Grant Date.”
EXECUTIVE STOCK OPTION AGREEMENT UNDER THE EDGE THERAPEUTICS, INC.Executive Stock Option Agreement • March 2nd, 2017 • Edge Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 2nd, 2017 Company Industry JurisdictionTHIS STOCK OPTION AGREEMENT (this “Agreement”) between Edge Therapeutics, Inc. (the “Corporation” or the “Company”) and the individual specified on the Notice of Grant (the “Optionee”) is made as of the date of grant specified on the Notice of Grant to which this Agreement is attached (the “Grant Notice”). The date of grant specified on the Grant Notice is referred to herein as the “Grant Date.”